Dr. Christopher T. Mallavarapu, MD

Dr. Mallavarapu practices at Infinite Medical in West Palm Beach, Florida.

Dr. Mallavarapu's NPI, 1649273715, was assigned on May 23, 2005. Dr. Mallavarapu graduated from State University of New York at Buffalo School of Medicine in 1988. Dr. Mallavarapu holds New York license 183914.

Dr. Mallavarapu's primary practice is Infinite Medical, at 534 Datura St, West Palm Beach, FL 33401 in Palm Beach County. The practice phone is (718) 964-6161.

Dr. Mallavarapu's primary practice is Infinite Medical in West Palm Beach, Florida. Dr. Mallavarapu is also affiliated with Buffalo General Medical Center/Gates Vascular Institute. The medical group on file is MedElite. Dmand AI also links Dr. Mallavarapu to 4 more hospitals, 7 medical groups and 5 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mallavarapu practices, 10 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mallavarapu's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Mallavarapu is licensed in New York.

CMS data shows 8,947 Medicare services from Dr. Mallavarapu across 18 procedure codes in 2024, for 2,422 Medicare patients. Medicare paid $775,759 for them. Every service was in an office.

CMS counts 2,422 Medicare patients who saw Dr. Mallavarapu in 2024. The largest group is 65 to 74, with 1,100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mallavarapu's median patient age at 71, with 52% women.

In 2024, Dr. Mallavarapu wrote 68 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $272 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Mallavarapu for performance year 2024, reported individually. Dr. Mallavarapu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mallavarapu as offering telehealth.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 18 general payments to Dr. Mallavarapu from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abiomed paid the most, $233.

Dr. Mallavarapu graduated from State University of New York at Buffalo School of Medicine in 1988.